Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (1-10 of 490) with videos related to

Pageof 49
Sort By:
Seminars in Hematology|August 30, 2001
Perspectives on the future of chronic myeloid leukemia treatmentF R Appelbaum
Leukemia|May 23, 2001
Who should be transplanted for AML?F R Appelbaum
Seminars in Hematology|October 26, 1999
Antibody-targeted therapy for myeloid leukemiaF R Appelbaum
Seminars in Hematology|July 1, 1990
Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseasesF R Appelbaum
Hematology/Oncology Clinics of North America|October 1, 1991
Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphomaF R Appelbaum
CA: a Cancer Journal for Clinicians|May 1, 1996
The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancerF R Appelbaum
Cancer Treatment and Research|January 1, 1990
Bone marrow transplantation for acute nonlymphocytic leukemia (ANL)F R Appelbaum
Stem Cells (Dayton, Ohio)|July 1, 1995
Allogeneic marrow transplantation and the use of hematopoietic growth factorsF R Appelbaum
Seminars in Hematology|July 1, 1989
The clinical use of hematopoietic growth factorsF R Appelbaum
Seminars in Hematology|July 1, 1988
Marrow transplantation for hematologic malignancies: a brief review of current status and future prospectsF R Appelbaum
Pageof 49

Showing results (1-10 of 490) with videos related to

Sort By:
Pageof 49
Seminars in Hematology|August 30, 2001
Perspectives on the future of chronic myeloid leukemia treatmentF R Appelbaum
Leukemia|May 23, 2001
Who should be transplanted for AML?F R Appelbaum
Seminars in Hematology|October 26, 1999
Antibody-targeted therapy for myeloid leukemiaF R Appelbaum
Seminars in Hematology|July 1, 1990
Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseasesF R Appelbaum
Hematology/Oncology Clinics of North America|October 1, 1991
Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphomaF R Appelbaum
CA: a Cancer Journal for Clinicians|May 1, 1996
The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancerF R Appelbaum
Cancer Treatment and Research|January 1, 1990
Bone marrow transplantation for acute nonlymphocytic leukemia (ANL)F R Appelbaum
Stem Cells (Dayton, Ohio)|July 1, 1995
Allogeneic marrow transplantation and the use of hematopoietic growth factorsF R Appelbaum
Seminars in Hematology|July 1, 1989
The clinical use of hematopoietic growth factorsF R Appelbaum
Seminars in Hematology|July 1, 1988
Marrow transplantation for hematologic malignancies: a brief review of current status and future prospectsF R Appelbaum
Pageof 49